Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/20/24
End: 03/25/24
Due: 03/25/25
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 02/28/24
End: 05/06/24
Due: 05/06/25
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 08/05/24
Due: 08/05/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Liver Transplantation for Hepatocellular Carcinoma Arising in Non-cirrhotic Liver: a Propensity Score-matched Retrospective Cohort Study of Two National Databases | NCT06364839 | Xiao Xu | user2@example.com | None | 2024-02-20 | 2024-03-25 | 2025-03-25 | - | - | 2025-07-14 |
| The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC | NCT06787534 | Xiao Xu | user2@example.com | None | 2015-01-01 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China | NCT06420791 | Xiao Xu | user2@example.com | None | 2024-02-28 | 2024-05-06 | 2025-05-06 | - | - | 2025-07-14 |
| Stratification for F-L Therapy After LT | NCT06564103 | Xiao Xu | user2@example.com | None | 2024-01-01 | 2024-08-05 | 2025-08-05 | - | - | 2025-07-14 |